Aveo Group (ASX:AOG) to be removed from the S&P/ASX 200

Company News

by Rachael Jones

S&P Dow Jones announced today that it will remove the Aveo Group (ASX:AOG) from the S&P/ASX 200, subject to final court approval of the scheme of arrangement whereby the company will be acquired by Brookfield Asset Management.

Aveo investors have vote to sell the company to the Canadian investment firm for $2 billion.

Aveo Group will be replaced by Avita Medical (ASX:AVH) in the S&P/ASX 200 effective at the open on November 14, 2019.

Shares in Aveo Group (ASX:AOG) closed 0.47 per cent lower at $2.14 yesterday.

Rachael Jones

Finance News Network
Rachael comes to FNN after working for Fairfax Media covering international breaking news, including the global economy and politics. She joined FNN in February 2018. She has reported on Australia’s finance news for various organisations since 2000 and has also interviewed a number of key business players, including Bill Gates. Rachael has also worked across a number of countries, including the UK and the US.